Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways
YcaO 依赖性天然产物生物合成途径的表征
基本信息
- 批准号:10220046
- 负责人:
- 金额:$ 34.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Actinobacteria classAddressAlkenesAmidinesAnabolismAntibioticsArchaeaAttentionBiochemicalBioinformaticsBiological AssayBiologyC-terminalCarbonChemicalsChemistryClinicalDataDeltaproteobacteriaDevelopmentDoctor of PhilosophyEnvironmentEnzymatic BiochemistryEnzymesEvaluationFamilyFamily memberFundingGene ClusterGenerationsGenesGeneticGenomicsGram-Positive BacteriaGrowthHumanHydro-LyasesIn VitroIsotopesKineticsKnowledgeLigationLogicLongevityMass Spectrum AnalysisMechanicsMedicineMicrobeModelingModificationMolecularMutation AnalysisN-terminalNatural ProductsNatureNucleotidesPathway interactionsPeptidesPositioning AttributePost-Translational Protein ProcessingPropertyProteinsReactionReportingResearchResolutionRibosomesRoleSourceSpeedStructureStructure-Activity RelationshipSulfidesSulfurThiamineThiazolesThioamidesVariantVertebral columnadenylateanalogbasecofactorcycloadditionenolaseinterestmembermicrobialnovelpyridinequantumrecruitsuccessthioether
项目摘要
Our group is broadly interested in the chemical biology of natural products with a strong focus on genomics-
based discovery, biosynthetic mechanistic enzymology, and determination of structure-activity relationships and
mode of action. Beyond their historical impact on medicine, natural products have inspired generations of syn-
thetic chemists and provided the necessary chemical probes to illuminate fundamental aspects of biology. One
natural product family that has received increased attention over the past several years are the ribosomally
synthesized and post-translationally modified peptides (RiPPs). While there are over 30 distinct structural clas-
ses of RiPP natural products reported, they are united by a common biosynthetic logic: a precursor peptide,
typically composed of an N-terminal leader and a C-terminal core, is ribosomally produced. The leader region
contains motifs that are recognized by the modification enzymes and the core region is where the modifications
take place. Upon maturation, the leader region is often removed prior to cellular export.
The current project focuses on natural product biosynthetic pathways that encode a member of the YcaO
superfamily. During the original funding period, we showed that YcaO enzymes were responsible for the ATP-
dependent activation of the peptide backbone to yield azoline heterocycles from Cys, Ser, and Thr residues of
the core peptide. During the current funding period, we discovered that two additional reaction types are cata-
lyzed by YcaO enzymes: thioamidation and macrolactamidation of the peptide backbone. No fewer than five
classes of RiPPs are now known to utilize a member of the YcaO superfamily, namely the linear azol(in)e-
containing peptides, thiopeptides, cyanobactins, bottromycins, and thioviridamides. Despite a wealth of
knowledge, we can only predict the modification type of approximately one-third of the YcaO superfamily. Our
bioinformatics analysis suggests that several new reaction types remain to be discovered.
For this renewal project, we tackle several outstanding questions with respect to YcaO-dependent natural
product biosynthesis. Aim I focuses on the structurally and enzymatically intriguing thiopeptide RiPP class. Aim
IA will overcome biosynthetic bottlenecks with respect to substrate tolerance in order to establish the elusive
structure-activity relationships and generate advanced biosynthetic intermediates that will enable the study of
late-stage transformations found within the class. Aim IB will determine the enzymatic mechanism and substrate
scope of the class-defining [4+2]-cycloaddition and establish why some are pyridine-forming while others are
dehydropiperidine-forming. Aim II focuses on peptide backbone thioamidation, in particular, deciphering the func-
tion of the TfuA partner protein and a novel desulfurase/lysase involved in mobilizing sulfur from Cys. Lastly, Aim
III characterizes divergent YcaO family members that appear in unique genomic contexts to discover new reac-
tions catalyzed by the superfamily. Our preliminary data, rich environment, and strong investigative team place
us in an ideal position to address these aims.
我们的团队对天然产物的化学生物学广泛感兴趣,重点关注基因组学-
基于发现,生物合成机制酶学,并确定结构-活性关系,
行动方式。除了它们对医学的历史影响外,天然产品还激发了几代人的合成,
他们是化学家,并提供了必要的化学探针来阐明生物学的基本方面。一
在过去的几年里,受到越来越多关注的天然产物家族是核糖体
合成的和后修饰的肽(RIPPs)。虽然有30多个不同的结构类-
据报道,RiPP天然产物的种类,它们通过共同的生物合成逻辑结合在一起:前体肽,
通常由N-末端前导序列和C-末端核心组成,是核糖体产生的。领导者区域
含有被修饰酶识别的基序,并且核心区域是修饰酶
发生。成熟后,前导区通常在细胞输出之前被去除。
目前的项目重点是编码YcaO成员的天然产物生物合成途径
超家族在最初的资助期间,我们发现YcaO酶负责ATP-
依赖性活化肽骨架以从Cys、Ser和Thr残基产生唑啉杂环,
核心肽在目前的资助期间,我们发现另外两种反应类型是催化剂,
通过YcaO酶裂解:肽骨架的硫代酰胺化和大环内酰胺化。不少于五
现在已知一类RIPP利用YcaO超家族的成员,即线性azol(in)e-,
含有肽、硫肽、蓝藻菌素、bottromycins和硫代病毒酰胺。尽管有丰富的
根据我们的知识,我们只能预测大约三分之一的YcaO超家族的修饰类型。我们
生物信息学分析表明,仍有几种新的反应类型有待发现。
对于这个更新项目,我们解决了几个悬而未决的问题,关于YcaO依赖的自然
产物生物合成。目的研究具有结构和酶学性质的硫肽类RiPP。目的
IA将克服底物耐受性方面的生物合成瓶颈,以建立难以捉摸的
结构-活性关系,并产生先进的生物合成中间体,这将使研究
在班级中发现的后期转换。目的研究酶的作用机理和底物
定义类别的[4+2]-环加成的范围,并确定为什么有些是吡啶形成的,而另一些是
脱氢哌啶形成。目的II侧重于肽骨架硫代酰胺化,特别是,破译功能,
TfuA伴侣蛋白和一种新的脱硫酶/裂解酶参与动员硫从半胱氨酸。最后,Aim
III表征了出现在独特基因组背景中的不同YcaO家族成员,以发现新的基因表达。
由超家族催化的反应我们的初步数据、丰富的环境和强大的调查团队
我们处于实现这些目标的理想位置。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas Alan Mitchell其他文献
Douglas Alan Mitchell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas Alan Mitchell', 18)}}的其他基金
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
发现核糖体来源抗菌药物的可扩展平台
- 批准号:
9899917 - 财政年份:2019
- 资助金额:
$ 34.15万 - 项目类别:
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
发现核糖体来源抗菌药物的可扩展平台
- 批准号:
10570218 - 财政年份:2019
- 资助金额:
$ 34.15万 - 项目类别:
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
发现核糖体来源抗菌药物的可扩展平台
- 批准号:
10359678 - 财政年份:2019
- 资助金额:
$ 34.15万 - 项目类别:
Genomics-Accelerated Natural Product Discovery
基因组学-加速天然产物发现
- 批准号:
10391633 - 财政年份:2017
- 资助金额:
$ 34.15万 - 项目类别:
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways
YcaO 依赖性天然产物生物合成途径的表征
- 批准号:
10389609 - 财政年份:2012
- 资助金额:
$ 34.15万 - 项目类别:
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways
YcaO 依赖性天然产物生物合成途径的表征
- 批准号:
10457879 - 财政年份:2012
- 资助金额:
$ 34.15万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.15万 - 项目类别:
Research Grant














{{item.name}}会员




